Primus In News
Tarnished by cough syrup deaths, India’s pharma industry tries to look beyond the stupor
21-07-2023
Nilaya Varma, Co-Founder and CEO of Primus Partners shares his views on the impact of the COVID-19 pandemic and the Russia-Ukraine war on vaccine exports from India, especially to African and Commonwealth of Independent States (CIS) countries. In addition, he stresses that the increasing cost of raw materials and the withdrawal of GST exemption has exacerbated challenges for Indian pharma companies. Read Now!
Explore Related Insights
- Diwali bonanza for auto sector: Vehicle prices set to drop as GST rates to be rationalised
- Bajaj’s CNG bike sputters amid high costs and weak demand
- Did Your Developer Charge You On The Basis Of Super Built-up Area
- Success & Gender Equity: Exclusive Interview with Aarti Harbhajanka, Consultant turned Entrepreneur
